Skip to main content

BMS 100 mg 3623 Pill - blue & white capsule/oblong, 18mm

Generic Name: atazanavir

Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule/Oblong and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 100 mg 3623

Reyataz 100 mg BMS 100 mg 3623
Reyataz 100 mg BMS 100 mg 3623


Generic Name
BMS 100 mg 3623
100 mg
Blue & White
18.00 mm
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00003-3623 (Discontinued)
Inactive Ingredients
crospovidone, lactose monohydrate, magnesium stearate, gelatin, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.